The underlying mechanism may involve the ability of metformin in increasing the sensitivity of liver, muscle, fat, and other tissues to insulin, thereby lowering blood sugar levels and reducing insulin resistance [59,60]. This evidence concerns the gene INS and Insulin resistance.